ECSP045242A - Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity - Google Patents
Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavityInfo
- Publication number
- ECSP045242A ECSP045242A EC2004005242A ECSP045242A ECSP045242A EC SP045242 A ECSP045242 A EC SP045242A EC 2004005242 A EC2004005242 A EC 2004005242A EC SP045242 A ECSP045242 A EC SP045242A EC SP045242 A ECSP045242 A EC SP045242A
- Authority
- EC
- Ecuador
- Prior art keywords
- ambroxol
- oral
- treatment
- painful conditions
- pharyngeal cavity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Abstract
La invención se refiere a la utilización de Ambroxol y sus sales farmacológicamente compatibles para la preparación de un medicamento para el tratamiento de estados dolorosos en la cavidad bucal y faríngea.The invention relates to the use of Ambroxol and its pharmacologically compatible salts for the preparation of a medicament for the treatment of painful conditions in the oral and pharyngeal cavity.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10208313A DE10208313A1 (en) | 2002-02-27 | 2002-02-27 | Ambroxol for the treatment of painful conditions in the mouth and throat |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP045242A true ECSP045242A (en) | 2004-09-28 |
Family
ID=27740434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2004005242A ECSP045242A (en) | 2002-02-27 | 2004-08-20 | Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1480626A1 (en) |
JP (1) | JP2005518435A (en) |
KR (1) | KR20040084944A (en) |
CN (1) | CN1638749A (en) |
AR (1) | AR038698A1 (en) |
AU (1) | AU2003210345B2 (en) |
BR (1) | BR0308038A (en) |
CA (1) | CA2477105A1 (en) |
DE (1) | DE10208313A1 (en) |
EC (1) | ECSP045242A (en) |
IS (1) | IS7417A (en) |
MX (1) | MXPA04008220A (en) |
MY (1) | MY144781A (en) |
PE (1) | PE20030830A1 (en) |
PL (1) | PL371584A1 (en) |
RU (1) | RU2311176C2 (en) |
TW (1) | TW200306804A (en) |
UA (1) | UA86741C2 (en) |
UY (1) | UY27679A1 (en) |
WO (1) | WO2003072094A1 (en) |
ZA (1) | ZA200405635B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10332486A1 (en) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of acute pain |
JP2005120063A (en) * | 2003-10-14 | 2005-05-12 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Ambroxol for treating inflammation at pharynx |
ITMI20032462A1 (en) * | 2003-12-16 | 2005-06-17 | Advance Holdings Ltd | METHOD TO PREPARE A CARAMEL CONTAINING AMBROXOLO AND THE CANDY SO OBTAINED |
DE102004021992A1 (en) * | 2004-05-03 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Topical preparation containing ambroxol |
JP2007084471A (en) * | 2005-09-21 | 2007-04-05 | Sunstar Inc | Composition for oral cavity and method of selecting product for oral cavity |
WO2007110871A2 (en) * | 2006-03-29 | 2007-10-04 | Naveh Pharma (1996) Ltd. | Methods and composition for treating sore throat |
JP5765934B2 (en) * | 2009-12-28 | 2015-08-19 | サンスター株式会社 | Oral composition |
JP6171683B2 (en) * | 2012-08-03 | 2017-08-02 | 大正製薬株式会社 | Solid preparation |
CN105769908B (en) * | 2016-05-06 | 2019-03-01 | 湖北凤凰白云山药业有限公司 | A kind of drug of preventing phlegm from forming and stopping coughing and preparation method thereof |
CN109982692A (en) | 2016-11-14 | 2019-07-05 | 王明武 | For treating the preparation and correlation technique of eye surface diseases |
CN106727621A (en) * | 2016-11-22 | 2017-05-31 | 郑州仁宏医药科技有限公司 | A kind of Western medicine powder for treating toothache |
JP6844394B2 (en) * | 2017-04-14 | 2021-03-17 | 大正製薬株式会社 | Solid composition |
EP3415143A1 (en) * | 2017-06-16 | 2018-12-19 | Kai-Uwe Kern | Bromhexine for the treatment of pain |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3485756D1 (en) * | 1983-09-17 | 1992-07-09 | Thomae Gmbh Dr K | ANTIADHAESIVE PROPHYLACTICA AND MEDICINAL PRODUCTS CONTAINING A SECRETOLYTICALLY EFFECTIVE BENZYLAMINE DERIVATIVE. |
DE3445226A1 (en) * | 1983-12-14 | 1985-08-01 | Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim | Pharmaceutical product for the treatment and prophylaxis of infections and of coughs and obstructive airway disorders |
US5122540A (en) * | 1986-02-28 | 1992-06-16 | W. Keith R. Watson | Method and composition for treating warts and throat soreness with DMSO and citric acid |
DE4415553A1 (en) * | 1994-05-03 | 1995-11-09 | Behringwerke Ag | Use of deoxyspergualin to prepare medicament |
CN1220598A (en) * | 1996-05-02 | 1999-06-23 | 大正制药株式会社 | Suspension of spraingly water-soluble acidic drug |
DE19933148A1 (en) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Lozenge containing ambroxol |
JP2001151677A (en) * | 1999-11-26 | 2001-06-05 | Taisho Pharmaceut Co Ltd | Composition for pharyngeal use |
DE20102817U1 (en) * | 2000-02-23 | 2001-06-07 | Bolder Arzneimittel Gmbh | Lozenges and chewing pills with cyclodextrin |
US6391886B1 (en) * | 2000-12-04 | 2002-05-21 | The Procter & Gamble Company | Oral compositions having improved consumer aesthetics |
-
2002
- 2002-02-27 DE DE10208313A patent/DE10208313A1/en not_active Withdrawn
-
2003
- 2003-02-25 JP JP2003570840A patent/JP2005518435A/en active Pending
- 2003-02-25 EP EP03742955A patent/EP1480626A1/en not_active Ceased
- 2003-02-25 CN CNA038047683A patent/CN1638749A/en active Pending
- 2003-02-25 PL PL03371584A patent/PL371584A1/en not_active Application Discontinuation
- 2003-02-25 MY MYPI20030651A patent/MY144781A/en unknown
- 2003-02-25 KR KR10-2004-7013393A patent/KR20040084944A/en active Search and Examination
- 2003-02-25 WO PCT/EP2003/001886 patent/WO2003072094A1/en active Application Filing
- 2003-02-25 RU RU2004129284/15A patent/RU2311176C2/en not_active IP Right Cessation
- 2003-02-25 UY UY27679A patent/UY27679A1/en not_active Application Discontinuation
- 2003-02-25 TW TW092103899A patent/TW200306804A/en unknown
- 2003-02-25 BR BR0308038-2A patent/BR0308038A/en not_active Expired - Fee Related
- 2003-02-25 MX MXPA04008220A patent/MXPA04008220A/en not_active Application Discontinuation
- 2003-02-25 UA UA20040907789A patent/UA86741C2/en unknown
- 2003-02-25 CA CA002477105A patent/CA2477105A1/en not_active Abandoned
- 2003-02-25 AU AU2003210345A patent/AU2003210345B2/en not_active Ceased
- 2003-02-26 PE PE2003000187A patent/PE20030830A1/en not_active Application Discontinuation
- 2003-02-26 AR ARP030100619A patent/AR038698A1/en not_active Suspension/Interruption
-
2004
- 2004-07-15 ZA ZA200405635A patent/ZA200405635B/en unknown
- 2004-08-19 IS IS7417A patent/IS7417A/en unknown
- 2004-08-20 EC EC2004005242A patent/ECSP045242A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2477105A1 (en) | 2003-09-04 |
AU2003210345A1 (en) | 2003-09-09 |
IS7417A (en) | 2004-08-19 |
PE20030830A1 (en) | 2003-10-31 |
RU2004129284A (en) | 2005-06-10 |
WO2003072094A1 (en) | 2003-09-04 |
KR20040084944A (en) | 2004-10-06 |
BR0308038A (en) | 2004-12-28 |
MY144781A (en) | 2011-11-15 |
PL371584A1 (en) | 2005-06-27 |
CN1638749A (en) | 2005-07-13 |
TW200306804A (en) | 2003-12-01 |
JP2005518435A (en) | 2005-06-23 |
UA86741C2 (en) | 2009-05-25 |
MXPA04008220A (en) | 2004-11-26 |
DE10208313A1 (en) | 2003-09-11 |
RU2311176C2 (en) | 2007-11-27 |
AU2003210345B2 (en) | 2009-01-29 |
UY27679A1 (en) | 2003-09-30 |
ZA200405635B (en) | 2005-05-31 |
AR038698A1 (en) | 2005-01-26 |
EP1480626A1 (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP045069A (en) | USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS | |
ECSP045242A (en) | Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity | |
EA200702522A1 (en) | SYSTEM OF DELIVERY OF MEDICINES IN THE CAVITY OF THE MOUTH AND METHODS OF ITS APPLICATION | |
DK1781277T3 (en) | Combination composition comprising Ibuprofen and Paracetamol | |
AR045972A1 (en) | FORMULATIONS OF RELEASE OF SUSTAINED LIBERATION WITH EFFECTIVENESS OF 24 HOURS | |
CY1114448T1 (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THESE IN WOMEN'S SEXUAL INTERFERENCE | |
EA200802208A1 (en) | APPLICATION OF FLIBANSTERIN FOR THE TREATMENT OF DISEASES OF THE SEXUAL TREATMENT IN THE POST-CLIMACTERNIC PERIOD | |
FR2878159B1 (en) | ORAL MEDICATION WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE IN MULTIMICROCAPSULAR FORM | |
CL2008000896A1 (en) | Periodic oral care maintaining composition comprising a basic amino acid; use in the therapeutic treatment of the buccal surface. | |
AR109644A2 (en) | PRADOFLOXACINE AND PHARMACEUTICAL COMPOSITION FOR THE SYSTEMIC TREATMENT OF BACTERIAL DISEASES IN THE ORAL CAVITY | |
PA8573101A1 (en) | TREATMENT AND PREVENTION OF OSTEOPOROSIS | |
PE20061314A1 (en) | ASSOCIATION BETWEEN FERROQUINE AND A DERIVATIVE OF ARTEMISININ FOR THE TREATMENT OF MALARIA | |
ECSP077843A (en) | PRURITE TREATMENT OR PREVENTION | |
PA8624501A1 (en) | PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS | |
BRPI0409175A (en) | oral pharmaceutical preparation for proton pumping antagonists | |
PA8800601A1 (en) | CRYSTAL CHEMOTHERAPEUTIC PRODUCTS | |
PA8800401A1 (en) | CRYSTAL CHEMOTHERAPEUTIC PRODUCTS | |
AR077451A1 (en) | USE OF BENZIDAMINE IN THE TREATMENT OF P40 DEPENDENT DISEASES | |
GT200300020A (en) | GENETIC POLYMORPHISMS IN THE PREPROTAQUIQUININE GEN | |
GT200200002A (en) | USE OF CHROMANS | |
GT200500267A (en) | USE OF EPOTILONES IN THE TREATMENT OF BONE METASTASIS | |
BRPI0412681A (en) | pharmaceutical composition for nasal administration of piribedil | |
UY28771A1 (en) | PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS. | |
UY29303A1 (en) | MEDICATIONS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | |
ITMI20022594A1 (en) | THERAPEUTIC COMBINATION FOR THE TREATMENT OF HYPERTENSION. |